JAMIE HICKS: Open Payments
NPI 1265916886 · WINDBER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,939 in 93 payments from 13 companies in 2025. Trend: 2023 $863 · 2024 $1,485 · 2025 $1,939
Food & beverage: $1,855Education: $84
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $354 |
| Ardelyx, Inc. | 11 | $289 |
| Janssen Biotech, Inc. | 7 | $237 |
| Regeneron Healthcare Solutions, Inc. | 11 | $234 |
| ABBVIE INC. | 10 | $224 |
| Madrigal Pharmaceuticals | 10 | $147 |
| Phathom Pharmaceuticals, Inc. | 9 | $114 |
| Novo Nordisk Inc | 6 | $111 |
| Aimmune Therapeutics, Inc. | 4 | $77 |
| Braintree Laboratories, Inc. | 3 | $58 |
Products named: ENTYVIO, IBSRELA, DUPIXENT, TREMFYA, REZDIFFRA, LINZESS, VOQUEZNA, Wegovy.
Industry payments across PA — which companies pay providers there.
